Second Sight Medical Products (NASDAQ:EYES)
Industry: Healthcare

Second Sight Medical Products, Inc., together with its subsidiaries, develops, manufactures, and markets prosthetic devices to restore functional vision of blind individuals in the United States, Canada, Europe, the Middle East, and Asia. It offers Argus II System, which treats outer retinal degenerations, such as retinitis pigmentosa. The company was formerly known as Second Sight LLC. and changed its name to Second Sight Medical Products, Inc. Second Sight Medical Products, Inc. was founded in 1998 and is headquartered in Sylmar, California.

Current Quote*
Last: $1.780
Change: -0.040
Book: $28.983
Volume: 98,406

As Of: 07/13 16:24 ET
*Quotes delayed by 20min.

Graphs for EYES


3 Month Graph


6 Month Graph


1 Year Graph